Literature DB >> 21147721

Iodine deficiency status and iodised salt consumption in Malaysia: findings from a national iodine deficiency disorders survey.

Rusidah Selamat1, Wan Nazaimoon Wan Mohamud, Ahmad Ali Zainuddin, Nor Syamlina Che Abdul Rahim, Suhaila Abdul Ghaffar, Tahir Aris.   

Abstract

A nationwide cross-sectional school-based survey was undertaken among children aged 8-10 years old to determine the current iodine deficiency status in the country. Determination of urinary iodine (UI) and palpation of the thyroid gland were carried out among 18,012 and 18,078 children respectively while iodine test of the salt samples was done using Rapid Test Kits and the iodometric method. The results showed that based on WHO/ ICCIDD/UNICEF criteria, the national median UI was 109 μg/L [25th, 75th percentile (67, 166)] showing borderline adequacy. The overall national prevalence of iodine deficiency disorders (IDD) with UI<100 μg/L was 48.2% (95% CI: 46.0, 50.4), higher among children residing in rural areas than in urban areas. The highest prevalence of UI<100 μg/L was noted among the aborigines [(81.4% (95% CI: 75.1, 86.4)]. The national total goitre rate (grade 1 and grade 2 goitre) was 2.1%. Of 17,888 salt samples brought by the school children, 28.2% (95% CI: 26.4, 30.2) were found to have iodine content. However, the overall proportion of the households in Malaysia using adequately iodised salt as recommended by Malaysian Food Act 1983 of 20-30 ppm was only 6.8% (95% CI: 5.1, 9.0). In conclusion, although a goitre endemic was not present in Malaysia, almost half of the states in Peninsular Malaysia still have large proportion of UI level <100 μg/L and warrant immediate action. The findings of this survey suggest that there is a need for review on the current approach of the national IDD prevention and control programme.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147721

Source DB:  PubMed          Journal:  Asia Pac J Clin Nutr        ISSN: 0964-7058            Impact factor:   1.662


  8 in total

Review 1.  The changing epidemiology of iodine deficiency.

Authors:  Mu Li; Creswell J Eastman
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

2.  Determine the iodine content of salt at the household level and its predictors in Bahirdar Town, Northwest Ethiopia.

Authors:  Temesgen Mersha; Terefe Derso; Musa Jemal; Shemsu Kedir; Bekri Mohammed
Journal:  Pan Afr Med J       Date:  2022-03-30

3.  Evaluation of the performance of a micromethod for measuring urinary iodine by using six sigma quality metrics.

Authors:  Husniza Hussain; Norhayati Mustafa Khalid; Rusidah Selamat; Wan Mohamud Wan Nazaimoon
Journal:  Ann Lab Med       Date:  2013-08-08       Impact factor: 3.464

Review 4.  The legislative framework for salt iodization in Asia and the Pacific and its impact on programme implementation.

Authors:  Karen Codling; Christiane Rudert; France Bégin; Juan Pablo Peña-Rosas
Journal:  Public Health Nutr       Date:  2017-09-07       Impact factor: 4.022

5.  Congenital Hypothyroidism in Children - A Cross-Sectional Study in a Tertiary Centre in Malaysia.

Authors:  Azriyanti Anuar Zaini; Yu Feng Tung; Nor Faizal Ahmad Bahuri; Muhammad Yazid Jalaludin
Journal:  J ASEAN Fed Endocr Soc       Date:  2020-04-21

6.  Defining Normative Sonographic Measurements of Neonatal Thyroid Volumes: Results of 165 Healthy Neonates from a Single Center in Northwest Malaysia.

Authors:  Noor Aneeza Md Noor; Asmah Omar; Wan Irnawati Wan Ab Rahman; Ahmad Zalizan Zainul
Journal:  J Med Ultrasound       Date:  2020-11-09

7.  A 10-Year Impact Evaluation of the Universal Salt Iodization (USI) Intervention in Sarawak, Malaysia, 2008-2018.

Authors:  Lim Kuang Kuay; Noor Ani Ahmad; Tan Beng Chin; Chan Ying Ying; Maznieda Mahjom; S Maria Awaluddin; Noor Syaqilah Shawaluddin; Tuan Mohd Amin Tuan Lah; Tahir Aris
Journal:  Nutrients       Date:  2022-04-11       Impact factor: 6.706

8.  Education achievements and goiter size ten years after iodized salt consuming.

Authors:  Mohammad Khajedaluee; Reza Rajabian; Mohsen Seyyednozadi
Journal:  Int J Prev Med       Date:  2013-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.